# FDA Inspection 1122373 - Apex Biologics - March 12, 2020

Source: https://www.keypedia.com/records/fda_inspections/apex-biologics/b0897cfb-55ec-414b-8295-dc59491145b6
Source feed: FDA_Inspections

> FDA Inspection 1122373 for Apex Biologics on March 12, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122373
- Company Name: Apex Biologics
- Inspection Date: 2020-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122373 - 2020-03-12](https://www.keypedia.com/records/fda_inspections/apex-biologics/a7164147-94e8-41d1-ab87-efcfc6e85b3d)

Company: https://www.keypedia.com/companies/apex-biologics/2c6ea7f9-49af-4418-ace5-76fa1e448878

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d